These findings indicated that COMMD3 plays a positive regulatory role in the growth and angiogenesis of subcutaneous HCC xenografts, and its effects may be achieved by regulating the HIF1α/VEGF/NF-κB signaling pathway. The gene discussed is HIF1A; the disease is hepatocellular carcinoma.